A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...